• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Abivax SA - American Depositary Shares (NQ:ABVX)

    117.35 +0.25 (+0.21%)
    Streaming Delayed Price Updated: 1:31 PM EST, Jan 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,654,191
    Open 119.88
    Bid (Size) 117.17 (100)
    Ask (Size) 117.79 (100)
    Prev. Close 117.10
    Today's Range 113.64 - 122.50
    52wk Range 4.770 - 148.83
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗
    And the share price appreciation could happen pretty soon. 
    Via The Motley Fool
    Top movers in Monday's pre-market session ↗
    Via Chartmill

    Performance

    YTD
    -12.3%
    -12.3%
    1 Month
    -15.4%
    -15.4%
    3 Month
    +28.3%
    +28.3%
    6 Month
    +1057.3%
    +1057.3%
    1 Year
    +1742.2%
    +1742.2%

    More News

    Read More
    ABVX Soars Pre-Market On Reports Of $17.5 Billion Eli Lilly Takeover Interest ↗
    Via Stocktwits
    News headline image
    Abivax Provides 2026 Corporate Outlook
    From Abivax
    Via GlobeNewswire
    News headline image
    Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Could This Potential Move Boost Eli Lilly's Prospects? ↗
    Via The Motley Fool
    News headline image
    The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade
    News headline image
    How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗
    Via Stocktwits
    News headline image
    Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics ETFs Stocks
    News headline image
    The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Why Abivax Stock Was on Fire Today ↗
    Via The Motley Fool
    News headline image
    Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Abivax to be Added to Nasdaq Biotechnology Index
    From Abivax
    Via GlobeNewswire
    News headline image
    The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
    From Abivax
    Via GlobeNewswire
    News headline image
    Abivax Presents Third Quarter 2025 Financial Results
    From Abivax
    Via GlobeNewswire
    News headline image
    2 Under-the-Radar Stocks That Have Soared This Year ↗
    Via The Motley Fool
    News headline image
    This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗
    Via The Motley Fool
    News headline image
    Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗
    Via The Motley Fool
    News headline image
    Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    6 Healthcare Stocks With Strong Upward Momentum ↗
    Via Benzinga
    News headline image
    This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Abivax SA - American Depositary Shares publicly traded?
    Yes, Abivax SA - American Depositary Shares is publicly traded.
    What exchange does Abivax SA - American Depositary Shares trade on?
    Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Abivax SA - American Depositary Shares?
    The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
    What is the current price of Abivax SA - American Depositary Shares?
    The current price of Abivax SA - American Depositary Shares is 117.35
    When was Abivax SA - American Depositary Shares last traded?
    The last trade of Abivax SA - American Depositary Shares was at 01/20/26 01:31 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.